Human hypertension caused by mutations in WNK kinases.

Area of Science:

• Genetics
• Nephrology
• Molecular Biology

Background:

• Hypertension is a significant public health issue with largely unknown origins.
• Pseudohypoaldosteronism type II (PHAll) is a Mendelian disorder characterized by hypertension, increased renal salt reabsorption, and impaired potassium and hydrogen ion excretion.

Purpose of the Study:

• To identify the genetic causes of pseudohypoaldosteronism type II.
• To investigate the role of WNK kinases in the pathogenesis of hypertension.

Main Methods:

• Genetic analysis to identify mutations in PHAII patients.
• Gene expression analysis to determine the effect of mutations on WNK1 and WNK4 expression.
• Immunolocalization studies to determine the subcellular localization of WNK1 and WNK4 proteins in the kidney.

Main Results:

• Two genes, WNK1 and WNK4, encoding serine-threonine kinases, were identified as causative for PHAII.
• Mutations in WNK1 involved large intronic deletions leading to increased gene expression.
• Missense mutations in WNK4 clustered in a conserved protein segment, and both proteins localized to the distal nephron.

Conclusions:

• WNK1 and WNK4 are key regulators of salt, potassium, and pH homeostasis in the kidney.
• Dysregulation of WNK kinases contributes to hypertension in PHAII.
• The WNK kinase signaling pathway represents a potential therapeutic target for hypertension.